company
LiverMultiScan receives regulatory clearance for clinical use in Australia
August 14, 2018
Large population imaging study reveals utility of LiverMultiScan’s cT1 measure
July 27, 2018
New paper released from the University of Nottingham on quantitative T1 mapping in liver disease
July 10, 2018
Good diagnostic accuracy with non-invasive Multiparametric MRI across a range of liver disease severity
Biotech Investors Should Consider The Four Horsemen
July 6, 2018
Multiparametric liver MRI could refine the way we currently approach testing of therapeutic candidates in preclinical models
July 3, 2018
Analysis of Biobank data shows 1 in 8 adults may have NASH
April 15, 2018
LiverMultiScan™ analysis of UK Biobank indicates as many as 1 in 8 adults may have non-alcoholic steatohepatitis (NASH)
April 13, 2018
LiverMultiScan™ Receives FDA 510(k) Clearance for Version 2 of Medical Device
November 27, 2017
